Tiago Fauth
Stock Analyst at Raymond James
(4.55)
# 1,042
Out of 4,491 analysts
303
Total ratings
50.4%
Success rate
13.6%
Average return
Main Sectors:
Stocks Rated by Tiago Fauth
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IONS Ionis Pharmaceuticals | Maintained: Buy | $104 → $87 | $65.48 | +32.87% | 2 | Jul 9, 2026 | |
| PRAX Praxis Precision Medicines | Reiterated: Buy | n/a | $337.41 | - | 2 | Jun 30, 2026 | |
| TNXP Tonix Pharmaceuticals Holding | Initiated Coverage: Buy | $26 | $12.31 | +111.21% | 1 | Jun 25, 2026 | |
| MPLT MapLight Therapeutics | Initiated Coverage: Buy | $46 | $38.51 | +19.45% | 1 | Jun 25, 2026 | |
| BBIO BridgeBio Pharma | Maintained: Buy | $76 → $98 | $88.94 | +10.19% | 18 | Jun 17, 2026 | |
| INSM Insmed | Maintained: Buy | $200 → $185 | $118.29 | +56.40% | 23 | May 8, 2026 | |
| PTCT PTC Therapeutics | Maintained: Buy | $108 → $95 | $89.08 | +6.65% | 22 | May 8, 2026 | |
| JAZZ Jazz Pharmaceuticals | Maintained: Buy | $227 → $239 | $247.67 | -3.50% | 2 | May 6, 2026 | |
| ALNY Alnylam Pharmaceuticals | Maintained: Hold | $395 → $377 | $335.00 | +12.54% | 14 | May 1, 2026 | |
| UTHR United Therapeutics | Initiated Coverage: Buy | $414 → $700 | $550.43 | +27.17% | 26 | Apr 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 | $1.25 | +380.00% | 1 | Apr 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $66 | $41.31 | +59.77% | 1 | Apr 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $26 → $20 | $11.72 | +70.65% | 11 | Mar 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $7 | $4.21 | +66.27% | 6 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 → $18 | $6.19 | +191.03% | 11 | Sep 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 → $31 | $80.16 | -61.33% | 6 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $101 | $35.65 | +183.35% | 7 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $88 → $65 | $34.42 | n/a | 21 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 → $7 | $6.23 | n/a | 4 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $91 | $80.41 | n/a | 5 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4 → $3 | $1.13 | n/a | 9 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $16 | $14.32 | n/a | 1 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $35 → $70 | $22.42 | n/a | 6 | Jun 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $120 | $59.89 | n/a | 8 | Jun 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $51 | $20.04 | n/a | 3 | Jun 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $89 | $280.51 | n/a | 22 | Jun 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $50.08 | n/a | 4 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 → $26 | $11.91 | n/a | 6 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $34 → $28 | $7.34 | n/a | 9 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $2 | $2.09 | n/a | 6 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 | $3.58 | n/a | 7 | Mar 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $38 → $34 | $2.21 | n/a | 6 | Mar 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $6 | $28.94 | n/a | 3 | Mar 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $13 | $2.30 | n/a | 1 | Dec 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $33 → $13 | $3.45 | n/a | 4 | Nov 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 → $14 | $2.63 | n/a | 2 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 → $14 | $11.33 | n/a | 3 | Aug 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $340 → $319 | $911.61 | n/a | 9 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $12 → $7 | $40.89 | n/a | 7 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $265 → $259 | $362.22 | n/a | 2 | Apr 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €240.00 | $807.50 | n/a | 1 | Oct 22, 2020 |
Ionis Pharmaceuticals
Jul 9, 2026
Maintained: Buy
Price Target: $104 → $87
Current: $65.48
Upside: +32.87%
Praxis Precision Medicines
Jun 30, 2026
Reiterated: Buy
Price Target: n/a
Current: $337.41
Upside: -
Tonix Pharmaceuticals Holding
Jun 25, 2026
Initiated Coverage: Buy
Price Target: $26
Current: $12.31
Upside: +111.21%
MapLight Therapeutics
Jun 25, 2026
Initiated Coverage: Buy
Price Target: $46
Current: $38.51
Upside: +19.45%
BridgeBio Pharma
Jun 17, 2026
Maintained: Buy
Price Target: $76 → $98
Current: $88.94
Upside: +10.19%
Insmed
May 8, 2026
Maintained: Buy
Price Target: $200 → $185
Current: $118.29
Upside: +56.40%
PTC Therapeutics
May 8, 2026
Maintained: Buy
Price Target: $108 → $95
Current: $89.08
Upside: +6.65%
Jazz Pharmaceuticals
May 6, 2026
Maintained: Buy
Price Target: $227 → $239
Current: $247.67
Upside: -3.50%
Alnylam Pharmaceuticals
May 1, 2026
Maintained: Hold
Price Target: $395 → $377
Current: $335.00
Upside: +12.54%
United Therapeutics
Apr 9, 2026
Initiated Coverage: Buy
Price Target: $414 → $700
Current: $550.43
Upside: +27.17%
Apr 9, 2026
Initiated Coverage: Buy
Price Target: $6
Current: $1.25
Upside: +380.00%
Apr 9, 2026
Initiated Coverage: Buy
Price Target: $66
Current: $41.31
Upside: +59.77%
Mar 5, 2026
Maintained: Buy
Price Target: $26 → $20
Current: $11.72
Upside: +70.65%
Feb 27, 2026
Maintained: Buy
Price Target: $10 → $7
Current: $4.21
Upside: +66.27%
Sep 4, 2025
Maintained: Buy
Price Target: $21 → $18
Current: $6.19
Upside: +191.03%
Aug 13, 2025
Maintained: Buy
Price Target: $25 → $31
Current: $80.16
Upside: -61.33%
Aug 7, 2025
Maintained: Buy
Price Target: $101
Current: $35.65
Upside: +183.35%
Jul 9, 2025
Maintained: Buy
Price Target: $88 → $65
Current: $34.42
Upside: n/a
May 28, 2025
Maintained: Buy
Price Target: $8 → $7
Current: $6.23
Upside: n/a
May 8, 2025
Maintained: Buy
Price Target: $91
Current: $80.41
Upside: n/a
Mar 4, 2025
Maintained: Hold
Price Target: $4 → $3
Current: $1.13
Upside: n/a
Aug 22, 2024
Initiated Coverage: Hold
Price Target: $16
Current: $14.32
Upside: n/a
Jun 17, 2024
Downgraded: Hold
Price Target: $35 → $70
Current: $22.42
Upside: n/a
Jun 13, 2023
Initiated Coverage: Buy
Price Target: $120
Current: $59.89
Upside: n/a
Jun 13, 2023
Initiated Coverage: Buy
Price Target: $51
Current: $20.04
Upside: n/a
Jun 13, 2023
Initiated Coverage: Hold
Price Target: $89
Current: $280.51
Upside: n/a
May 16, 2023
Reiterated: Buy
Price Target: $4
Current: $50.08
Upside: n/a
May 11, 2023
Reiterated: Buy
Price Target: $29 → $26
Current: $11.91
Upside: n/a
May 5, 2023
Maintained: Buy
Price Target: $34 → $28
Current: $7.34
Upside: n/a
Apr 5, 2023
Reiterated: Sell
Price Target: $2
Current: $2.09
Upside: n/a
Mar 24, 2023
Reiterated: Hold
Price Target: $8
Current: $3.58
Upside: n/a
Mar 10, 2023
Maintained: Buy
Price Target: $38 → $34
Current: $2.21
Upside: n/a
Mar 10, 2023
Reiterated: Buy
Price Target: $7 → $6
Current: $28.94
Upside: n/a
Dec 16, 2022
Initiated Coverage: Buy
Price Target: $13
Current: $2.30
Upside: n/a
Nov 17, 2022
Downgraded: Hold
Price Target: $33 → $13
Current: $3.45
Upside: n/a
Aug 15, 2022
Maintained: Buy
Price Target: $19 → $14
Current: $2.63
Upside: n/a
Aug 12, 2022
Maintained: Buy
Price Target: $28 → $14
Current: $11.33
Upside: n/a
Mar 3, 2022
Maintained: Hold
Price Target: $340 → $319
Current: $911.61
Upside: n/a
Aug 2, 2021
Downgraded: Sell
Price Target: $12 → $7
Current: $40.89
Upside: n/a
Apr 28, 2021
Maintained: Buy
Price Target: $265 → $259
Current: $362.22
Upside: n/a
Oct 22, 2020
Maintained: Hold
Price Target: €240.00
Current: $807.50
Upside: n/a